Serial Number 98001170
Registration 7517789
700

Registration Progress

Application Filed
May 17, 2023
Under Examination
May 21, 2024
Approved for Publication
Mar 6, 2024
Published for Opposition
Mar 26, 2024
Registered
Sep 24, 2024

Trademark Image

Basic Information

Serial Number
98001170
Registration Number
7517789
Filing Date
May 17, 2023
Registration Date
September 24, 2024
Published for Opposition
March 26, 2024
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 24, 2024
Registration
Registered
Classes
005

Rights Holder

Mylan Pharmaceuticals Inc.

03
Address
3711 Collins Ferry Road
Morgantown, WV 26505

Ownership History

Mylan Pharmaceuticals Inc.

Original Applicant
03
Morgantown, WV

Mylan Pharmaceuticals Inc.

Owner at Publication
03
Morgantown, WV

Mylan Pharmaceuticals Inc.

Original Registrant
03
Morgantown, WV

Legal Representation

Attorney
Samir Patel

USPTO Deadlines

Next Deadline
1695 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240924)
Due Date
September 24, 2030
Grace Period Ends
March 24, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

24 events
Date Code Type Description Documents
Sep 24, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Sep 24, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 19, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Aug 19, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jul 2, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
May 23, 2024 IUAF S USE AMENDMENT FILED Loading...
Jul 1, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 23, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
May 21, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 26, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 26, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 6, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 6, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 20, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 20, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 20, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 20, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 16, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 16, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 16, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 7, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 20, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jun 18, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 20, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of thyroid disorders
First Use Anywhere: Dec 13, 2022
First Use in Commerce: Dec 13, 2022

Additional Information

Design Mark
The mark consists of bold outlines of three raindrop shapes, the purple rain drop is the largest rain drop, the green drop sits within the purple rain drop and the redorange rain drop sits within the green rain drop; the color white represents background and transparent areas and is not part of the mark.
Color Claim
The color(s) Purple, green, red and orange is/are claimed as a feature of the mark.

Classification

International Classes
005